We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy.

list of NY corporations

How Aduhelm, an Unproven Alzheimer’s Drug, Got Approved


Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab.
read more

Source: NY Times


15:29, July 20, 2021 Pam Belluck, Sheila Kaplan and Rebecca Robbins

You may also like

News